Platelet-derived growth factor (PDGF) is a mitogen and chemoattractant for vascular smooth muscle cells (SMC) in vitro, but its activities in vivo remain largely undefined. We infused recombinant PDGF-BB (0.01-0.30 mg/kg per d i.v.) into rats subjected to carotid injury. PDGF-BB produced a small increase (two-to threefold) in medial SMC proliferation. More importantly, PDGF-BB greatly increased (20-fold) the intimal thickening and the migration of SMC from the media to the intima during the first 7 d after injury. These data provide support for the hypothesis that PDGF, and perhaps other platelet factors, might play an important role in the movement of mesenchymal cells into zones of injury undergoing repair. (J. Clin.
Introduction
Platelet-derived growth factor (PDGF)' was originally defined by its ability to stimulate fibroblast and arterial smooth muscle cell (SMC) proliferation in vitro (1) . Subsequent investigation has demonstrated that PDGF also affects a number of other cellular functions including migration (2) . Nevertheless, the activities of PDGF in vivo are still unknown even under conditions ofinjury. The vascular response to injury is a particularly important issue because ofthe hypothesis implicating PDGF in SMC proliferation and the formation of the intimal lesion (3) . Whether the in vitro definition of PDGF as a growth factor applies to its function in vivo in pathological states and during growth and development is not known.
Blood vessels undergoing angioplasty respond to the trauma of the catheter by a series of thrombotic and cellular events including early platelet accumulation, replication of medial SMCs, migration into the intima of replicating and non-replicating SMC into the media, and chronic replication of intimal SMC (4) (5) (6) . In this study, we attempted to determine the effect ofintravascularly infused PDGF on migration and proliferation of SMCs in rat carotid artery subjected to a de-endothe-lializing injury. Although PDGF can exist in three dimeric forms, PDGF-BB is a good candidate for study because it is the major isoform found in rat platelets, and human PDGF-BB is available in recombinant form (7) . Moreover, the PDGF Bchain can bind to either the alpha or the beta form ofthe PDGF receptor, whereas the PDGF A-chain interacts only with the alpha form (8) . Hence, PDGF-BB can bind to any of the highaffinity receptor dimers (beta-beta, alpha-beta, or alpha-alpha).
Although mRNA for both receptor subunits is detected in normal aorta, PDGF-receptor beta subunit mRNA is much more abundant and expression is increased in the injured vessel at sites ofactive SMC proliferation (9) . Thus, it appears likely that the response of rat arterial SMC to PDGF would be mediated through PDGF-BB binding to PDGF-receptor beta subunits.
Methods
Reagents. Recombinant human PDGF-BB (rPDGF-BB) was a gift from ZymoGenetics, Inc. (Seattle, WA). It was prepared by expression of human PDGF B-chain in the yeast Saccharomyces cerevisiae. PDGF-BB homodimers were purified to > 95% homogeneity, as assessed by amino-terminal sequencing and by SDS-PAGE under reducing or nonreducing conditions (10) . The concentrations of PDGF are based on the data from amino acid analysis.
Animal model. The left carotid arteries of 3-mo-old, male, SpragueDawley rats (Simonsen Laboratories, Inc., Gilroy, CA) were denuded of endothelium by passage of either a 2-F balloon catheter or a loop of nylon filament as previously described (6, 1 1). Animals were anesthetized with 1.0 ml/kg i.m. of a solution containing acepromazine 1 mg/ ml (Fermenta Animal Health Co., Kansas City, MO), ketamine 50 mg/ml (Aveco, Inc., Fort Dodge, IA), and rompun 5 mg/ml (Mobay Corp., Shawnee, KS) in normal saline and were cared for according to institutional guidelines. rPDGF-BB was prepared as a solution in 10 mM acetic acid containing 0.25% BSA and infused continuously with a syringe infusion pump (Harvard Apparatus, Dedham, MA) over Morphology. At the end of each experiment the carotid arteries were fixed by perfusion with 4% paraformaldehyde in PBS, pH 7.4, at 100 mmHg, embedded in Epon (two segments/animal), cross-sectioned, and stained with methylene blue. Intimal and medial cross-sectional areas were measured as described previously (13) . SMC Measurement of SMC migration. In previously reported experiments using carotid balloon-injured rats receiving a continuous infusion of tritiated thymidine, we have shown that a population of unlabeled SMC appears in the intima (4) . We have concluded that these cells must migrate from the media to the intima without dividing since all cycling cells, regardless ofthe number ofrounds ofdivision, become labeled with tritium. The media is the only source ofSMC and no SMC are present in the intima ofuntraumatized vessels. Hence, a minimum estimate of SMC migration can be obtained by quantitating the number of unlabeled intimal nuclei in histological cross-sections ofarteries from rats receiving a continuous intraperitoneal infusion ofthymidine. This estimate is only a minimum because any cell that migrates and subsequently proliferates will not be counted. We have investigated the possibility that the apparently unlabeled cells have replicated but have incorporated less thymidine than the labeled cells. Since the labeling index is not affected by the dose or the specific activity of the infused tritiated thymidine or the autoradiographic exposure time, we are reasonably certain that the unlabeled intimal SMCs have never replicated (4, 12, 15) .
Results
Effect ofrPDGF-BB on intimal and medial SMC proliferation in carotid arteries subjected to balloon orfilament loop denudation. Experiments were done first in rats with preexisting intimal thickening induced by balloon damage of the carotid artery since intimal SMCs express a great abundance of the PDGF-receptor beta subunit and replication is relatively low (6, 9) . At various times after balloon injury, rPDGF-BB (100 g in 400 g animals) was infused intraarterially over 6 h by means of a cannula placed in the aortic arch. Intimal SMC proliferation was increased two-to fourfold above control in samples retrieved from PDGF-treated animals 2 6 wk after carotid injury (Fig. 1 A) . The labeling index was increased among the intimal SMCs, particularly those near the luminal surface, but not among medial SMCs. No significant increase in replication was seen at 2 wk, perhaps because background levels ofreplication were already high. These data demonstrate for the first time that infused PDGF can stimulate SMC replication.
To determine whether rPDGF-BB could also stimulate medial SMC to proliferate, rPDGF-BB (10 ,ug/rat) was infused intraarterially over 6 h beginning immediately after carotid injury. As expected, the thymidine labeling index in ballooned carotid arteries was elevated at 48 h (injured carotid: 20%; uninjured carotid: 0.06%). rPDGF-BB administration, however, produced no further increase (Fig. 1 B) . Since the failure to see an effect could have been due to a high background of replication, the experiment was repeated using a milder form of arterial injury (1 1, 16) . When endothelium is removed completely by passage of a loop of nylon filament, the labeling index of medial SMC at 48 h is only slightly elevated (filament loop denudation: 1-2%; balloon injury: 15-25%) (11, 13) . Infusion ofrPDGF-BB (10 sg/rat over 6 h) produced a two-to threefold increase in medial SMC proliferation at 48 h after filament loop denudation (Fig. 1 B) . The same effect could be achieved whether rPDGF-BB was given intraarterially or intravenously over 6 h (intraarterial: 4.0±0.9%; intravenous: 2.7±0.4%).
There was a slight dose response, with the maximum being at 1Ouggi.a. over (Fig. 2, B and D) . The number of unlabeled intimal nuclei was greatly increased in rats receiving rPDGF-BB ( Fig. 3 A and Table I ). These unlabeled cells had migrated without replicating. The number of labeled nuclei was also increased, but only in proportion to the number of unlabeled cells (Fig. 3 A) .
The cumulative labeling index ofthe intimal SMC over 7 d was not affected by the rPDGF-BB infusion (Fig. 3 B) . On the other hand, the cumulative labeling index for the medial SMC increased two-to fivefold. This observation is consistent with the small increase in pulse thymidine labeling index observed at 48 h after filament loop denudation and a 6-h infusion of PDGF (Fig. 1 B) .
The rPDGF-BB infusion did not increase the thymidine labeling index or induce migration of SMC in normal, untraumatized carotid arteries. 
Discussion
Since platelets adhere, spread, and degranulate on the denuded artery within seconds after injury, platelet granule contents, including PDGF-BB, have been posited to play a significant role in the subsequent migration and proliferation of SMC and the formation of intimal thickening (3) . Intimal thickening is diminished ifthe animals are made thrombocytopenic (17, 18) . However, early gene expression and the initial proliferative response of medial SMCs after balloon injury are not affected by the lack of platelets (18) . Moreover, we could find only a modest effect of infused rPDGF-BB on the extent of SMC replication in the period immediately after injury. Under similar circumstances, basic fibroblast growth factor, which is not found in platelets and is released from injured SMCs, produces a dramatic stimulation of medial SMC replication (19, 20) . These results raise the possibility that PDGF and other platelet factors have little effect on the initial proliferative response of medial SMC but might affect migration or subsequent proliferation in the intima.
The data in the present study demonstrate that the infusion of rPDGF-BB increased SMC replication and migration. The data also suggest that migration may account for most of the effect of rPDGF-BB on intimal thickening and that once the SMC are in the intima they undergo a similar number of divisions, regardless of the presence or absence of infused rPDGF-BB. This interpretation arises from three sources. First, in a detailed analysis of the kinetics of SMC replication after balloon injury (4), we found that although proliferation was important a substantial portion of intimal accumulation of SMCs depended on migration. Second, in vitro studies from our laboratories have shown that SMCs from the neointima have altered proliferative capacities, including the ability to proliferate independently of exogenous PDGF (21, 22 ent study we find that the dose-dependent increase in intimal cell number or mass is directly proportional to the increase in cell migration (Fig. 3) . The simplest interpretation ofthese data is that most of the effect of infused rPDGF-BB is on migration followed by a number of divisions in the intima that may be largely independent of the infused growth factor. This interpretation is further supported by a recent study by Ferns et al. (23) . These experiments used nude rats treated with high doses of a polyclonal antibody to human platelet PDGF (which cross-reacts with rat platelet PDGF) and subjected to balloon injury of the carotid artery. They observed a 40% reduction in intimal thickening, but no change in thymidine labeling index, at 8 d after surgery. These findings are consistent with our own and support the conclusion that platelet PDGF may play an important role in SMC migration.
The factors responsible for intimal SMC proliferation have not been defined. Early on (e.g., 7-14 d), it is quite possible that various mitogens, including PDGF-BB from platelets (7) or PDGF from the SMCs themselves, maximally stimulate intimal SMC replication (9) . Infusion ofrPDGF-BB would then be Certain caveats should be expressed about these conclusions. First, as with any in vivo pharmacological study, the effects ofthe infused material may represent a direct or indirect action of PDGF on the cells under study. As noted earlier, the SMCs possess the receptors for PDGF and hence could respond directly to the infused PDGF-BB. It is also possible that PDGF could stimulate leukocyte invasion ofthe injured artery and that these cells would then produce factors to influence SMC function (24, 25). However, no increase in leukocyte adherence and accumulation was noted. Second, it is premature to extend any of these results to atherosclerosis or restenosis in the human atherosclerotic vessel after surgical manipulation. Those processes may be much more complex because of the mixture of inflammatory cells in the pathologic tissue, the effects of multiple or prolonged thrombotic episodes, or the unusual properties ofthe intimal SMC themselves (9, 21, (26) (27) (28) (29) (30) .
In summary, these data represent the first evidence that PDGF can have mitogenic and chemotactic effects for SMCs in vivo. The data also suggest that the chemotactic effect may be more important than the mitogenic effect in the formation of the neointima after injury of the rat carotid artery.
